nph insulin + glargine insulin + aspart insulin

This is a combination regimen of three different insulins used in the management of diabetes mellitus, particularly type 1 and type 2 diabetes. The components are: - **NPH insulin** (Neutral Protamine Hagedorn): An intermediate-acting human insulin that provides basal glycemic control. - **Glargine insulin**: A long-acting recombinant human insulin analog that mimics basal endogenous insulin secretion with a prolonged, peakless action profile. - **Aspart insulin**: A rapid-acting recombinant human insulin analog designed for mealtime glucose control. These insulins act by binding to the human insulin receptor, stimulating its tyrosine kinase activity and triggering downstream signaling pathways that promote cellular glucose uptake and metabolism. This combination is not available as a single premixed product but may be used together in complex regimens tailored to individual patient needs for optimal glycemic control[2][4][5]. Each component has distinct pharmacokinetic properties, allowing for both basal (background) and prandial (mealtime) blood sugar management.